Cargando…

Current status of surgical treatment of colorectal liver metastases

Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Feng, Tang, Bin, Jin, Tian-Qiang, Dai, Chao-Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264988/
https://www.ncbi.nlm.nih.gov/pubmed/30510936
http://dx.doi.org/10.12998/wjcc.v6.i14.716
_version_ 1783375591321370624
author Xu, Feng
Tang, Bin
Jin, Tian-Qiang
Dai, Chao-Liu
author_facet Xu, Feng
Tang, Bin
Jin, Tian-Qiang
Dai, Chao-Liu
author_sort Xu, Feng
collection PubMed
description Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the only curative treatment for patients with colorectal LM (CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease (EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM.
format Online
Article
Text
id pubmed-6264988
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-62649882018-12-03 Current status of surgical treatment of colorectal liver metastases Xu, Feng Tang, Bin Jin, Tian-Qiang Dai, Chao-Liu World J Clin Cases Review Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the only curative treatment for patients with colorectal LM (CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease (EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM. Baishideng Publishing Group Inc 2018-11-26 2018-11-26 /pmc/articles/PMC6264988/ /pubmed/30510936 http://dx.doi.org/10.12998/wjcc.v6.i14.716 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Review
Xu, Feng
Tang, Bin
Jin, Tian-Qiang
Dai, Chao-Liu
Current status of surgical treatment of colorectal liver metastases
title Current status of surgical treatment of colorectal liver metastases
title_full Current status of surgical treatment of colorectal liver metastases
title_fullStr Current status of surgical treatment of colorectal liver metastases
title_full_unstemmed Current status of surgical treatment of colorectal liver metastases
title_short Current status of surgical treatment of colorectal liver metastases
title_sort current status of surgical treatment of colorectal liver metastases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264988/
https://www.ncbi.nlm.nih.gov/pubmed/30510936
http://dx.doi.org/10.12998/wjcc.v6.i14.716
work_keys_str_mv AT xufeng currentstatusofsurgicaltreatmentofcolorectallivermetastases
AT tangbin currentstatusofsurgicaltreatmentofcolorectallivermetastases
AT jintianqiang currentstatusofsurgicaltreatmentofcolorectallivermetastases
AT daichaoliu currentstatusofsurgicaltreatmentofcolorectallivermetastases